These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23770674)

  • 1. Does time-intensive ERP attenuate the negative impact of comorbid personality disorders on the outcome of treatment-resistant OCD?
    Dèttore D; Pozza A; Coradeschi D
    J Behav Ther Exp Psychiatry; 2013 Dec; 44(4):411-7. PubMed ID: 23770674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder.
    Shavitt RG; Valério C; Fossaluza V; da Silva EM; Cordeiro Q; Diniz JB; Belotto-Silva C; Cordioli AV; Mari J; Miguel EC
    Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):91-9. PubMed ID: 20077119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin reuptake inhibitor-cognitive behavioural therapy-second generation antipsychotic combination for severe treatment-resistant obsessive-compulsive disorder. A prospective observational study.
    Tundo A; Salvati L; Cieri L; Balestrini V; Di Spigno D; Orazi F; Iommi M; Necci R
    Int J Psychiatry Clin Pract; 2022 Nov; 26(4):395-400. PubMed ID: 35323098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Intensive Cognitive Behaviour Therapy in a Residential Setting for People with Severe Obsessive Compulsive Disorder: A Large Open Case Series.
    Veale D; Naismith I; Miles S; Childs G; Ball J; Muccio F; Darnley S
    Behav Cogn Psychother; 2016 May; 44(3):331-46. PubMed ID: 26122913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How resistant is 'treatment-resistant' obsessive-compulsive disorder in youth?
    Krebs G; Isomura K; Lang K; Jassi A; Heyman I; Diamond H; Advani J; Turner C; Mataix-Cols D
    Br J Clin Psychol; 2015 Mar; 54(1):63-75. PubMed ID: 25130442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
    Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early maladaptive schemas impact on long-term outcome in patients treated with group behavioral therapy for obsessive-compulsive disorder.
    Sunde T; Hummelen B; Himle JA; Walseth LT; Vogel PA; Launes G; Haaland VØ; Haaland ÅT
    BMC Psychiatry; 2019 Oct; 19(1):318. PubMed ID: 31655556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.
    Costa DLC; Diniz JB; Requena G; Joaquim MA; Pittenger C; Bloch MH; Miguel EC; Shavitt RG
    J Clin Psychiatry; 2017 Jul; 78(7):e766-e773. PubMed ID: 28617566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder.
    Besiroglu L; Çetinkaya N; Selvi Y; Atli A
    Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agomelatine augmentation in obsessive compulsive disorder: a preliminary report.
    Tzavellas E; Karaiskos D; Ilias I; Liappas I; Paparrigopoulos T
    Psychiatriki; 2014; 25(3):179-84. PubMed ID: 25367661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
    Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
    Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
    Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
    Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schema therapy augmented exposure and response prevention in patients with obsessive-compulsive disorder: Feasibility and efficacy of a pilot study.
    Thiel N; Jacob GA; Tuschen-Caffier B; Herbst N; Külz AK; Hertenstein E; Nissen C; Voderholzer U
    J Behav Ther Exp Psychiatry; 2016 Sep; 52():59-67. PubMed ID: 27016846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
    Simpson HB; Gorfinkle KS; Liebowitz MR
    J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal mood changes in patients with obsessive-compulsive disorder.
    Tan O; Metin B; Ünsalver BÖ; Sayar GH
    Psychiatry Res; 2017 Dec; 258():166-170. PubMed ID: 27979316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar disorder comorbidity in patients with obsessive-compulsive disorder: Prevalence and predictors.
    Domingues-Castro MS; Torresan RC; Shavitt RG; Fontenelle LF; Ferrão YA; Rosário MC; Torres AR
    J Affect Disord; 2019 Sep; 256():324-330. PubMed ID: 31201983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Obsessive Compulsive Personality Disorder on Cognitive Behaviour Therapy for Obsessive Compulsive Disorder.
    Gordon OM; Salkovskis PM; Bream V
    Behav Cogn Psychother; 2016 Jul; 44(4):444-59. PubMed ID: 27246860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder.
    Koran LM; Aboujaoude E; Gamel NN
    J Clin Psychiatry; 2009 Nov; 70(11):1530-5. PubMed ID: 19573497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal event-related potential study of selective serotonin reuptake inhibitor therapy in treatment-naïve pediatric obsessive compulsive disorder patients.
    Yamamuro K; Ota T; Iida J; Kishimoto N; Nakanishi Y; Matsuura H; Uratani M; Okazaki K; Kishimoto T
    Psychiatry Res; 2016 Nov; 245():217-223. PubMed ID: 27552672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.